Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, Eirion Therapeutics announced in a press release. “Right now ...

And here is the kicker—stress can actually lead to more hair loss, creating a vicious cycle. While daily shedding is part of the natural hair cycle, noticing patchy hair loss could be a sign of ...

It develops pharmaceutical products based on its multi-matrix technology. The company’s pipeline products include breezula for androgenetic alopecia; CB-01-35 targets ulcerative colitis and proctitis; ...